Author： Geier Mark R Geier David A Zahalsky Arthur C
Publisher： Informa Healthcare
ISSN： 1474-0338
Source： Expert Opinion on Drug Safety, Vol.2, Iss.2, 2003-03, pp. : 113-122
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Hepatitis B vaccination not linked to multiple sclerosis
Inpharma, Vol. 1, Iss. 1225, 2000-01 ,pp. :
Access to resources
Recommend
Hepatitis B vaccination impact of thiomersal alert
Inpharma, Vol. 1, Iss. 1290, 2001-01 ,pp. :
Recombinant Hepatitis B Vaccination in Renal Failure Patients
Current Pharmaceutical Biotechnology, Vol. 4, Iss. 2, 2003-04 ,pp. :
Hepatitis B Vaccination in HIV-Infected Subjects
Current Molecular Pharmacology, Vol. 1, Iss. 3, 2008-01 ,pp. :
Hepatitis B vaccination: to B or not to B?
Inpharma, Vol. 1, Iss. 1237, 2000-01 ,pp. :